24:30

Key Insights: MPN and MDS

HMP Education

17:13

Genetic Basis of MDS

HMP Education

24:31

New Mouse Models of MDS

HMP Education

21:12

Cytokines, Cells and Inflammation in MPN

HMP Education

27:39

Interplay of Somatic and Germline Variants in MPN

HMP Education

27:38

Biology and Therapy of Eosinophilic MPNs

HMP Education

21:26

The WHO Updated Diagnostic Criteria for ET, PV & MF

HMP Education

22:18

Splanchnic Vein Thrombosis and MPN: Diagnosis and Therapy

HMP Education

22:00

Update on Long-acting Interferons for MPN

HMP Education

22:04

JAK Inhibitors for ET and PV: What Have We Learned So Far

HMP Education

19:12

An Approach to Diagnosis and Staging of MDS: From Morphology to Genetics

HMP Education

21:55

A Unified Approach to Lower Risk MDS: Standard and Emerging Therapies

HMP Education

22:08

A Unified Approach to Higher Risk MDS: Standard and Emerging Therapies

HMP Education

22:13

How to Approach HMA Failure?

HMP Education

24:51

Stem Cell Transplant Approaches to MDS

HMP Education

19:54

Therapy for “Early Myelofibrosis”: Pros and Cons

HMP Education

18:38

Mutation-based Risk Stratification Approaches in Myelofibrosis: Any Real Clinical Utility?

HMP Education

17:43

Influence of Mutational Status on Timing, Outcome and Post-transplant Management of Myelofibrosis

HMP Education

19:23

Novel Agents and Combination Therapies in Myelofibrosis

HMP Education